Sylvia K Plevritis

pekerjaan: peneliti

Seri

There is nothing here

Create a new serie

Karya

There is nothing here

Create a new work

Artikel 122

Date

Judul

Pengarang

2022-02-22

Visualization, benchmarking and characterization of nested single-cell heterogeneity as dynamic forest mixtures

Xiaojiang Xu, Guang Hu, Jian-Liang Li, Trevor K Archer, Sylvia K Plevritis
2020-02-10

Disparities of national lung cancer screening guidelines in the U.S. population

Eric J Feuer, Sylvia K Plevritis, Summer S. Han
2020-05-07

A human lung tumor microenvironment interactome identifies clinically relevant cell-type cross-talk

Matt van de Rijn
2020-05-11

Multi-omic single-cell snapshots reveal multiple independent trajectories to drug tolerance in a melanoma cell line

Yapeng Su, Jessica K. Wang, Jihoon W Lee, Kaitlyn Takata, Antoni Ribas, Wei Wei, Guideng Li, David Baltimore, James R. Heath, Garry P. Nolan, Alexander M. Xu
2020-05-01

Cost-Effectiveness Analysis of Lung Cancer Screening in the United States

Sylvia K Plevritis
2020-07-12

Risk-Based lung cancer screening: A systematic review

Sylvia K Plevritis, Summer S. Han
2020-09-25

Correction: Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study

Eric J Feuer, Sylvia K Plevritis, Summer S. Han
2019-09-30

A comparative modeling analysis of risk-based lung cancer screening strategies

Kevin ten Haaf, Jihyoun Jeon, Iakovos Toumazis
2019-11-05

Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling Study

Kevin ten Haaf, Sylvia K Plevritis
2019-11-01

Precision Medicine in Pancreatic Disease-Knowledge Gaps and Research Opportunities: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop

Jyoti Choudhary, David C Whitcomb, Holger R Roth
2019-11-08

TRAIL-induced variation of cell signaling states provides nonheritable resistance to apoptosis

Reema Baskar, Zumana Khair, Samuel C Kimmey, Sean C Bendall, Garry P. Nolan, Sylvia K Plevritis
2019-12-06

Mapping lung cancer epithelial-mesenchymal transition states and trajectories with single-cell resolution

Samuel C Kimmey, Sean C Bendall, Robert Tibshirani
2019-05-28

Sparse discriminative latent characteristics for predicting cancer drug sensitivity from genomic features

David A Knowles, Gina Bouchard, Sylvia K Plevritis
2019-05-23

Cost-Effectiveness Analysis of Lung Cancer Screening Accounting for the Effect of Indeterminate Findings

Iakovos Toumazis, Sylvia K Plevritis, Summer S. Han
2018-04-01

Introduction to the Cancer Intervention and Surveillance Modeling Network (CISNET) Breast Cancer Models

Oğuzhan Alagöz, Eric J Feuer, Sylvia K Plevritis, Jeanne S Mandelblatt
2018-06-01

Contributions of Screening and Treatment to Mortality From Breast Cancer-Reply

Sylvia K Plevritis, Jeanne S Mandelblatt
2018-09-01

Caution Needed for Analyzing the Risks of Second Cancers

Sylvia K Plevritis, Summer S. Han
2018-11

Change in Survival in Metastatic Breast Cancer with Treatment Advances: Meta-Analysis and Systematic Review

George Sledge, Sylvia K Plevritis, Allison W Kurian, Jeanne S Mandelblatt
2018-07-01

-Expressing Cancer-Associated Fibroblasts Mediate Metabolic Reprogramming in Human Lung Adenocarcinoma

Matt van de Rijn, Gina Bouchard, Sandy Napel
2018-04

Common Model Inputs Used in CISNET Collaborative Breast Cancer Modeling

Ronald E Gangnon, Diana Miglioretti, Kathleen A. Cronin, Sylvia K Plevritis, Allison W Kurian, Jeanne S Mandelblatt
2018-01-01

Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012

Oğuzhan Alagöz, Ronald E Gangnon, Yisheng Li, Sylvia K Plevritis, Allison W Kurian, Jeanne S Mandelblatt
2018-04-01

Comparing CISNET Breast Cancer Models Using the Maximum Clinical Incidence Reduction Methodology.

Marjolein van Ballegooijen
2018-04-01

Comparing CISNET Breast Cancer Incidence and Mortality Predictions to Observed Clinical Trial Results of Mammography Screening from Ages 40 to 49

Yisheng Li, Oğuzhan Alagöz, Sylvia K Plevritis, Jeanne S Mandelblatt
2018-04-01

Estimating Breast Cancer Survival by Molecular Subtype in the Absence of Screening and Adjuvant Treatment

Sylvia K Plevritis
2018-04-01

A Molecular Subtype-Specific Stochastic Simulation Model of US Breast Cancer Incidence, Survival, and Mortality Trends from 1975 to 2010.

Sylvia K Plevritis
2018-04-13

DRUG-NEM: Optimizing drug combinations using single-cell perturbation response to account for intratumoral heterogeneity.

Robert Tibshirani, Garry P. Nolan
2018-10-16

A radiogenomic dataset of non-small cell lung cancer

Sandy Napel, Daniel Rubin, Ann N C Leung, Andrew Quon, Sylvia K Plevritis, Sebastian Echegaray, Michael Kadoch, Olivier Gevaert, Joseph B Shrager, Shaimaa Bakr
2017-01-10

The impact of overdiagnosis on the selection of efficient lung cancer screening strategies

Pamela M McMahon, Vidit N Munshi, Eric J Feuer, Sylvia K Plevritis, Summer S. Han
2017-04-04

Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study

Kevin ten Haaf, Jihyoun Jeon, Martin C Tammemagi, Eric J Feuer, Rafael Meza
2017-01-31

Predictive radiogenomics modeling of EGFR mutation status in lung cancer

Olivier Gevaert, Daniel Rubin, Sandy Napel, Ann N C Leung, Sylvia K Plevritis, Sebastian Echegaray, Joseph B Shrager, Amanda Khuong
2017-07-20

Non-Small Cell Lung Cancer Radiogenomics Map Identifies Relationships between Molecular and Imaging Phenotypes with Prognostic Implications

Olivier Gevaert, Daniel Rubin, Sandy Napel, Ann N C Leung, Sylvia K Plevritis, Sebastian Echegaray, Joseph B Shrager
2017-07-12

Evaluating the impact of varied compliance to lung cancer screening recommendations using a microsimulation model

Iakovos Toumazis, Sylvia K Plevritis, Summer S. Han

Human - wd:Q89453368

Selamat datang di Inventaire

perpustakaan teman-teman dan komunitas anda

pelajari lebih lanjut